People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

Semaglutide, the drug used in Ozempic, has been linked to lowering the risk of Alzheimer's disease in the past. So, it was ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The U.S. Food and Drug Administration (FDA) has approved Onapgo (apomorphine hydrochloride) injection, the first and only ...

Studying the symptom experience of persons with Parkinson's disease (PD ... A descriptive correlational design with face-to-face interviews was used to study the extent of distress related ...

Nonmotor symptoms may appear during the course of Parkinson's disease, complicating the advanced phase in particular, but are also common in the premotor phase of Parkinson's disease. The ...

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

This is why it is crucial to pay attention to other associated symptoms of Parkinson's. In an interaction with the OnlyMyHealth team, Dr Shruti Satish Vadke, Consultant - Neurology, Manipal ...

Fox Foundation, found that an overwhelming 84% of patients with Parkinson's disease report struggling with sleep issues. These were strongly linked to increased symptoms of depression, greater ...